PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Cambridge Healthtech Institute

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

CHI's 2nd Annual FAST - Functional Analysis & Screening Technologies Congress on November 17-19 - Keynote Presentations delivered by George Church, Anna Collén, Meir Click and more - FASTCongress.com / HealthTech.com
CHI's 2nd Annual FAST - Functional Analysis & Screening Technologies Congress on November 17-19

 

NewswireToday - /newswire/ - Needham, MA, United States, 2014/07/25 - Keynote Presentations delivered by George Church, Anna Collén, Meir Click and more - FASTCongress.com / HealthTech.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Cambridge Healthtech Institute (CHI) is pleased to announce final details for its 2nd annual FAST: Functional Analysis & Screening Technologies Congress, an international event dedicated to improving in vitro cell models and phenotypic screening to advance drug discovery and development. The congress will take place on November 17-19, 2014 at the Hyatt Boston Harbor Hotel in Boston, MA.

Over 250 R&D teams are anticipated to attend the six conferences happening at the FAST Congress: Phenotypic Drug Discovery (Parts I & II), Engineering Functional 3D Models,
Screening and Functional Analysis of 3D Models, Organotypic Culture Models for Toxicology, and Physiologically-Relevant Cellular Tumor Models for Drug Discovery.

Keynote presentations include:

Personalized Reading and Writing of Organs
George Church, Ph.D., Professor, Genetics, Harvard Medical School; Professor, Health Sciences and Technology, Harvard and MIT; Founding Core Faculty Member, Platform Lead, Synthetic Biology, Wyss Institute for Biologically Inspired Engineering, Harvard University

Phenotypic Discovery at AstraZeneca
Anna Collén, Ph.D., Director, Reagents and Assay Development, AstraZeneca R&D, Mölndal, Sweden

Organs-on-Chips to Screen for Drug Efficacy and Toxicity
Kristin Fabre, Ph.D., Scientific Program Manager, NCATS, National Institutes of Health

In silico Lead Finding through Holistic Understanding of Screening Data from Multiple Approaches
Meir Glick, Ph.D., Head, In Silico Lead Discovery Cambridge, Center for Proteomic Chemistry, Novartis Institutes for BioMedical Research

Organs-on-Chips: Highly Functional Microphysiological Systems to Predict Human Physiology and Pathobiology
Geraldine A. Hamilton, Ph.D., Senior Staff Scientist, Wyss Institute for Biologically Inspired Engineering, Harvard University

Phenotypic Screening: A New Perspective
Jing Li, Ph.D., Director, Genomics and Phenotypic Screening, Merck Research Laboratories

An All-Human Microphysiologic Liver System for Carcinoma Metastasis
Alan H. Wells, M.D., D.M.Sc., Vice Chair and Thomas J. Gill III Professor, Pathology, University of Pittsburgh

Scaling and Systems Biology for Integrating Multiple Organs-on-a-Chip
John P. Wikswo, Ph.D., Founding Director, Vanderbilt Institute for Integrative Biosystems Research and Education and Gordon A. Cain University Professor, Biomedical Engineering, Vanderbilt University

In addition to the six conference tracks, the FAST Congress includes five short courses, panel discussions, and an exhibit/poster hall displaying technologies and research revolutionizing early-stage drug discovery.

Important Dates:
Early registration discount deadline: August 22, 2014
Poster abstract submission deadline: October 10, 2014
Advanced registration discount deadline: October 10, 2014

For additional information and to register, visit FASTCongress.com/.

Writers and editors are encouraged to attend. To request a press pass, contact Lisa Scimemi at lscimemi[.]healthtech.com.

About Cambridge Healthtech Institute (CHI)

Cambridge Healthtech Institute (chicorporate.com), founded in 1992, is the industry leader in providing superior-quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett Educational Services, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, Cambridge Healthtech Media Group, and The Knowledge Foundation.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Cambridge Healthtech Institute

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


CHI's 2nd Annual FAST - Functional Analysis & Screening Technologies Congress on November 17-19

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: James Prudhomme - HealthTech.com 
781-972-5400 jprudhomme[.]healthtech.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Cambridge Healthtech Institute securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Cambridge Healthtech Institute / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR
Commodity Chemicals Market Projected to be Resilient by 2020 Says Persistence Market Research
Cell Expansion Market Set to Garner Staggering Revenues by 2025 Reports PMR
Soft Tissue Sarcoma Treatment Market Revenue Predicted To Go Up by 2025 Finds Persistence Market Research
Persistence Market Research Publishes Biopharmaceutical Membrane Filtration Market Forecast Over 2017-2025
Global Tablet Processing & Packaging Equipment Market to Reach USD 5,268.8 Million by 2022
FDA Approves Genentech’s Actemra (Tocilizumab) for Giant Cell Arteritis
BTG and HealthLoop Collaborate on IO Loop™ - An Exclusive Service to Connect Patients and Interventional Oncologists throughout Treatment
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  MagLar, Inc.

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)